Advanced company searchLink opens in new window

CYTOSPIRE THERAPEUTICS LIMITED

Company number 14688240

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
21 Oct 2024 PSC07 Cessation of 4Bio Ventures Iii Gp Llp as a person with significant control on 3 October 2024
11 Oct 2024 SH01 Statement of capital following an allotment of shares on 3 October 2024
  • GBP 3,033.8986
31 Jul 2024 AA Accounts for a small company made up to 31 March 2024
11 Jul 2024 MR04 Satisfaction of charge 146882400001 in full
05 Mar 2024 CS01 Confirmation statement made on 23 February 2024 with updates
26 Feb 2024 MA Memorandum and Articles of Association
22 Jan 2024 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of alteration of Articles of Association
15 Dec 2023 MA Memorandum and Articles of Association
15 Dec 2023 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES01 ‐ Resolution of adoption of Articles of Association
06 Dec 2023 PSC02 Notification of 4Bio Ventures Iii Gp Llp as a person with significant control on 30 November 2023
06 Dec 2023 PSC07 Cessation of Mark Uden as a person with significant control on 30 November 2023
06 Dec 2023 SH01 Statement of capital following an allotment of shares on 30 November 2023
  • GBP 2,627.1189
06 Dec 2023 PSC07 Cessation of Natalie Marianne Mount as a person with significant control on 30 November 2023
06 Dec 2023 AP01 Appointment of Mr Owen Philip Smith as a director on 22 November 2023
22 Aug 2023 MR01 Registration of charge 146882400002, created on 18 August 2023
04 Jul 2023 MR01 Registration of charge 146882400001, created on 29 June 2023
26 May 2023 MA Memorandum and Articles of Association
26 May 2023 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of adoption of Articles of Association
22 May 2023 PSC02 Notification of Abingworth Bioventures 8 Gp Lp as a person with significant control on 28 April 2023
17 May 2023 AP01 Appointment of Dr Balaji Muralidhar as a director on 2 May 2023
17 May 2023 SH01 Statement of capital following an allotment of shares on 2 May 2023
  • GBP 1,677.9662
21 Mar 2023 AA01 Current accounting period extended from 28 February 2024 to 31 March 2024
24 Feb 2023 NEWINC Incorporation
  • MODEL ARTICLES ‐ Model articles adopted (Amended Provisions)

Statement of capital on 2023-02-24
  • GBP 1,000